Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of relevance. This is page number 11.
Order by Relevance | Date
Total 2139 results found since Jan 2013.
No, the HPV vaccine isn ’t optional
A lot of parents ask me, about the HPV vaccine,“Isn’t that the optional one?” Well, let me walk you through why my answer to that question is a hard“no.” Human papillomavirus (HPV) is a virus that causes warts and several types of cancer. There are over 200 different strains of HPV, some of which […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
Source: Kevin, M.D. - Medical Weblog - May 19, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/chad-hayes" rel="tag" > Chad Hayes, MD < /a > < /span > Tags: Meds Pediatrics Source Type: blogs
What we can learn from Marcia Cross about HPV vaccination
Recently, Desperate Housewives star Marcia Cross made headlines by discussing her diagnosis of anal cancer and her husband ’s diagnosis of throat cancer, revealing that both had been related to the human papillomavirus, or HPV. The move was brave, as the actress broke free from the stigma related to anal cancer and sexually transmitted diseases. More […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
Source: Kevin, M.D. - Medical Weblog - June 14, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/brian-kim" rel="tag" > Brian Kim, MD < /a > < /span > Tags: Conditions Gastroenterology Oncology/Hematology Source Type: blogs
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Publication date: Available online 26 June 2019Source: The LancetAuthor(s): Mélanie Drolet, Élodie Bénard, Norma Pérez, Marc Brisson, Hammad Ali, Marie-Claude Boily, Vincenzo Baldo, Paul Brassard, Julia M L Brotherton, Denton Callander, Marta Checchi, Eric P F Chow, Silvia Cocchio, Tina Dalianis, Shelley L Deeks, Christian Dehlendorff, Basil Donovan, Christopher K Fairley, Elaine W Flagg, Julia W GarganoSummaryBackgroundMore than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vaccinating girls and women a...
Source: The Lancet - June 27, 2019 Category: General Medicine Source Type: research
If we don ’t pay now to vaccinate our children, they will pay later
The HPV vaccine saves lives. It does so by reducing a person’s chance of being infected by the human papilloma virus, a virus that causes a whole range of cancers including, most importantly, cervical cancer. Vaccinate your teenage daughter against HPV, and you will increase the chance she will live to old age. Simple as that. […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
Source: Kevin, M.D. - Medical Weblog - June 27, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/peter-ubel" rel="tag" > Peter Ubel, MD < /a > < /span > Tags: Meds Pediatrics Source Type: blogs
The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women
The number of studies, the sample size, and the prevalence on HPV infection in general population of each province of China AbstractHuman papillomavirus (HPV) infection which continues to be the most common sexually transmitted disease, has been identified as a major risk factor for cervical cancer. Therefore, it is very important to understand and grasp the distribution of HPV in Chinese population, and make the foundation for the development of cervical cancer vaccine in China. An extensive search strategy was conducted in multiple literature databases. All retrieved studies were screened by October 31, 2018. The prevale...
Source: Cancer Medicine - July 26, 2019 Category: Cancer & Oncology Authors: Bo Zhu,
Yunyong Liu,
Tingting Zuo,
Xiaoli Cui,
Mengdan Li,
Jing Zhang,
Huihui Yu,
Haozhe Piao Tags: ORIGINAL RESEARCH Source Type: research
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
CONCLUSIONS: The immunogenicity of two-dose and three-dose HPV vaccine schedules, measured using antibody responses in young females, is comparable. The quadrivalent vaccine probably reduces external genital lesions and anogenital warts in males compared with control. The nonavalent and quadrivalent vaccines offer similar protection against a combined outcome of cervical, vaginal, and vulval precancer lesions or cancer. In people living with HIV, both the bivalent and quadrivalent HPV vaccines result in high antibody responses. For all comparisons of alternative HPV vaccine schedules, the certainty of the body of evidence ...
Source: Cochrane Database of Systematic Reviews - November 21, 2019 Category: General Medicine Authors: Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, Riveros-Balta AX, Low N, Henschke N Tags: Cochrane Database Syst Rev Source Type: research
Quality Assessment of Websites Providing Information on Human Papillomavirus Vaccines in Thailand.
CONCLUSION: Most of the websites met standards in terms of writing/editing and content accuracy. However, fundamental information regarding the benefits and adverse events associated with HPV vaccination were infrequently reported, the editorial process and transparency issues were rarely addressed.
PMID: 31759374 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - November 26, 2019 Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials.
CONCLUSIONS: This review supports the premise that one HPV vaccine dose may be as effective in preventing HPV infection as multi-dose schedules in healthy young women. However, it also highlights the paucity of available evidence from purpose-designed, prospectively-randomised trials. Results from ongoing clinical trials assessing the efficacy and immunogenicity of single-dose HPV vaccination compared to currently-recommended schedules are awaited.
PMID: 31870572 [PubMed - as supplied by publisher]
Source: Vaccine - December 19, 2019 Category: Allergy & Immunology Authors: Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D Tags: Vaccine Source Type: research
Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews.
CONCLUSIONS: Systematic reviews have found evidence that the available HPV vaccines are safe, effective, and efficacious against vaccine-type HPV infection and HPV-associated cellular changes, including precancerous and benign lesions.
PRACTICAL IMPLICATIONS: Dentists may use this resource to better understand the literature on the potential harms and benefits of HPV vaccination.
PMID: 31983391 [PubMed - as supplied by publisher]
Source: Journal of the American Dental Association - January 29, 2020 Category: Dentistry Tags: J Am Dent Assoc Source Type: research
The role of programmed cell death ligand-1/ programmed cell death-1 (PD-L1/PD-1) in HPV-induced cervical cancer and potential for their use in blockade therapy.
CONCLUSION: Recent research developments have led to an entirely new class of drugs using antibodies against the PD-L1/PD-1 thus promoting the body's immune system to fight the cancer. The expression and roles of the PD-L1/ PD-1 axis in the progression of cervical cancer provide great potential for using PD-L1/PD-1 antibodies as a targeted cancer therapy.
PMID: 32003657 [PubMed - as supplied by publisher]
Source: Current Medicinal Chemistry - January 26, 2020 Category: Chemistry Authors: Zhang L, Zhao Y, Tu Q, Xue X, Zhu X, Zhao KN Tags: Curr Med Chem Source Type: research
High-Risk Human Papillomavirus Identification in Precancerous Cervical Intraepithelial Lesions
Conclusions
Human papillomavirus tests are a critical component for cervical cancer screening, and understanding of these tests helps test results interpretation and patients' triage.
Source: Journal of Lower Genital Tract Disease - April 1, 2020 Category: OBGYN Tags: Management HPV Assoc Conditions Source Type: research
Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval of our HPV test for the cobas 6800 and 8800 Systems enables molec...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news
Trends in recurrent respiratory papillomatosis treatment.
Abstract
Recurrent respiratory papillomatosis (RRP) consist of benign tumours along the airway caused by human papillomavirus infection. Papillomas may cause changes in phonation and obstruct the airway. The purpose of this study was to evaluate the different surgical and adjuvant therapies available for the treatment of this condition reported between 2014-2018. A PubMed search was performed for RRP treatment articles published between 2014 -2018. Forty articles that encompassed 1425 patients with RRP met the criteria. Of these, 24 articles evaluate the use of adjuvant therapies such as bevacizumab, human papillo...
Source: Acta Otorrinolaringologica Espanola - April 16, 2020 Category: ENT & OMF Authors: Ballestas SA, Shelly S, Soriano RM, Klein A Tags: Acta Otorrinolaringol Esp Source Type: research
IJERPH, Vol. 17, Pages 3464: Studying Public Perception about Vaccination: A Sentiment Analysis of Tweets
This study uses a sample of 9581 vaccine-related tweets in the period January 1, 2019 to April 5, 2019. The time period is of the essence because during this time, a measles outbreak was prevalent throughout the United States and a public debate was raging. Sentiment analysis is applied to the sample, clustering the data into topics using the term frequency&ndash;inverse document frequency (TF-IDF) technique. The analyses suggest that most (about 77%) of the tweets focused on the search for new/better vaccines for diseases such as the Ebola virus, human papillomavirus (HPV), and the flu. Of the remainder, about hal...
Source: International Journal of Environmental Research and Public Health - May 14, 2020 Category: Environmental Health Authors: Raghupathi Ren Raghupathi Tags: Article Source Type: research
Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review
ConclusionsHPV vaccination and screening interventions may be cost effective in LMICs and potentially reduce the lifetime risk, economic burden, and associated mortality. However, it is important to consider the factors that influence the cost effectiveness of cervical cancer prevention interventions for better outcomes to be realised.
Source: Applied Health Economics and Health Policy - May 28, 2020 Category: Health Management Source Type: research
